Stem Cell Technology: A Promising Treatment for Rheumatoid Arthritis
Rheumatoid arthritis manifests itself mostly as stiff, swollen, and painful joints, though its underlying mechanism is more complex than that of osteoarthritis. The disease is caused by an abnormality in the immune system (called autoimmunity) where white blood cells attack the tissue in the joints. This results in symptoms similar to those of osteoarthritis, though treatment could be harder due to the autoimmunity mechanism of the disease. As the specific cause of the disease remains unknown, there is currently no cure for rheumatoid arthritis. The disease lasts a lifetime and, if left untreated, could lead to serious joint damage and disability.
Rheumatoid arthritis is the second most common form of arthritis in Australia. While early diagnosis is able to dramatically slow disease progression, its similarities in symptoms to arthritis make it hard to diagnose. Most treatments of rheumatoid arthritis involve painkilling medication that does not address the damage in the joints. Doctors often offer education and advice in dealing with the disease in milder cases, but disease-modifying medication that suppresses immune function and slows disease progression may be required in moderate cases. Some patients with severe rheumatoid arthritis may require an artificial joint to replace the damaged one.
However, this is only a temporary solution as the immune system will continue to attack the body’s tissue, potentially necessitating a repeat procedure. Current treatments for the disease are therefore limited in efficacy.
How Can Stem Cells Help with Rheumatoid Arthritis?
The breakthrough in stem cell research carries much excitement in treating chronic diseases such as rheumatoid arthritis. Stem cells are able to replicate to large numbers, and in large numbers, they are able to transform into different cell types to replace the corresponding ones lost. This effectively regenerates any lost or damage tissue in the body.
The powerful regenerative potential of stem cells holds promise in addressing what conventional medicine cannot. Cells and tissues lost cannot be restored, only proactively halted and delayed by drugs and medicine. Stem cells can reactively be used to regenerate the damaged tissue.
In the case of rheumatoid arthritis, stem cells are able to regenerate the joint lining that cushions the bones from impact and constant contact. They have also demonstrated the ability to regulate the immune system, slowing the progression of autoimmunity-mediated joint damage.
AMPC: The Latest Innovation in Stem Cell Research
Among the ranks of stem cells lies Autologous Multi-lineage Potential Cells (AMPC). AMPC are stem cells that boast higher safety and efficacy than current stem cells used in treatment.
AMPC are pluripotent and autologous, unlike their conventional counterparts. This means they can differentiate into any cell type of the body, and are extracted and used on the same person. This overcomes problems with mesenchymal stem cells (MSC) currently used for joint treatments, where the stem cells are painful to extract, and lengthy to produce.
AMPC also exhibit a higher safety profile than other stem cells used for treatment. They are cultured without genetic manipulation and in a closed system that minimises contamination risk. All samples are also screened before they are released for treatment and all procedures insured by Vero Insurance, one of Australia’s largest medical insurers.
Your safety will be ensured with AMPC stem cell therapy.